Clinical Trial Update: Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy [NA]

View source ↗

Summary

Clinical trial evaluating neurotoxicity in patients with metastatic gastric cancer who receive Phycocare or placebo during oxaliplatin-based chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Phycocare

Snippet

Sponsor: Nantes University Hospital | Conditions: Metastatic Gastric Cancer | NA | Status: ACTIVE_NOT_RECRUITING